R&D Ensuring R&D investments deliver maximum potential: Notable ... As the drug development landscape becomes more complex, pharmaceutical and biotech companies understand their business strategies have to evolve.
R&D Precision medicine, NGS, and the quantum leap in biomarkers In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific, a company
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.